Trial Profile
Valproate dose reduction and its clinical evaluation by introducing lamotrigine in Japanese women with epilepsy – single arm, multicenter, and open-label study
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary) ; Valproic acid
- Indications Epilepsy
- Focus Pharmacodynamics
- Sponsors GSK
- 14 Aug 2017 New trial record